Standard
ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors. / Kaipio, Katja; Chen, Ping; Roering, Pia; Huhtinen, Kaisa; Mikkonen, Piia; Östling, Päivi; Lehtinen, Laura; Mansuri, Naziha; Korpela, Taina; Potdar, Swapnil; Hynninen, Johanna; Auranen, Annika; Grénman, Seija; Wennerberg, Krister; Hautaniemi, Sampsa; Carpén, Olli.
In:
Journal of Pathology, Vol. 250, No. 2, 2020, p. 159-169.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Kaipio, K, Chen, P, Roering, P, Huhtinen, K, Mikkonen, P, Östling, P, Lehtinen, L, Mansuri, N, Korpela, T, Potdar, S, Hynninen, J, Auranen, A, Grénman, S
, Wennerberg, K, Hautaniemi, S & Carpén, O 2020, '
ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors',
Journal of Pathology, vol. 250, no. 2, pp. 159-169.
https://doi.org/10.1002/path.5356APA
Kaipio, K., Chen, P., Roering, P., Huhtinen, K., Mikkonen, P., Östling, P., Lehtinen, L., Mansuri, N., Korpela, T., Potdar, S., Hynninen, J., Auranen, A., Grénman, S.
, Wennerberg, K., Hautaniemi, S., & Carpén, O. (2020).
ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors.
Journal of Pathology,
250(2), 159-169.
https://doi.org/10.1002/path.5356Vancouver
Kaipio K, Chen P, Roering P, Huhtinen K, Mikkonen P, Östling P et al.
ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors.
Journal of Pathology. 2020;250(2):159-169.
https://doi.org/10.1002/path.5356Author
Kaipio, Katja ; Chen, Ping ; Roering, Pia ; Huhtinen, Kaisa ; Mikkonen, Piia ; Östling, Päivi ; Lehtinen, Laura ; Mansuri, Naziha ; Korpela, Taina ; Potdar, Swapnil ; Hynninen, Johanna ; Auranen, Annika ; Grénman, Seija ; Wennerberg, Krister ; Hautaniemi, Sampsa ; Carpén, Olli. / ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors. In: Journal of Pathology. 2020 ; Vol. 250, No. 2. pp. 159-169.
Bibtex
@article{6f0b8b3b1e8d4f81a15bd6964e0004c1,
title = "ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors",
author = "Katja Kaipio and Ping Chen and Pia Roering and Kaisa Huhtinen and Piia Mikkonen and P{\"a}ivi {\"O}stling and Laura Lehtinen and Naziha Mansuri and Taina Korpela and Swapnil Potdar and Johanna Hynninen and Annika Auranen and Seija Gr{\'e}nman and Krister Wennerberg and Sampsa Hautaniemi and Olli Carp{\'e}n",
year = "2020",
doi = "10.1002/path.5356",
language = "English",
volume = "250",
pages = "159--169",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "JohnWiley & Sons Ltd",
number = "2",
}
RIS
TY - JOUR
T1 - ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors
AU - Kaipio, Katja
AU - Chen, Ping
AU - Roering, Pia
AU - Huhtinen, Kaisa
AU - Mikkonen, Piia
AU - Östling, Päivi
AU - Lehtinen, Laura
AU - Mansuri, Naziha
AU - Korpela, Taina
AU - Potdar, Swapnil
AU - Hynninen, Johanna
AU - Auranen, Annika
AU - Grénman, Seija
AU - Wennerberg, Krister
AU - Hautaniemi, Sampsa
AU - Carpén, Olli
PY - 2020
Y1 - 2020
U2 - 10.1002/path.5356
DO - 10.1002/path.5356
M3 - Journal article
C2 - 31595974
VL - 250
SP - 159
EP - 169
JO - Journal of Pathology
JF - Journal of Pathology
SN - 0022-3417
IS - 2
ER -
